样式: 排序: IF: - GO 导出 标记为已读
-
Performance of a handheld point of care ultrasonography to assess IUD position compared to conventional transvaginal ultrasonography Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-03-05 K. G. Araujo, A. Yoshida, C. R. T. Juliato, L. O. Sarian, S. Derchain
To compare the performance of the abdominal handheld point-of-care ultrasonography (POCUS) Butterfly-iQ to gold standard transvaginal ultrasonography (US) in identifying the position of intrauterin...
-
The role of progestin subdermal implant in the management of adenomyosis: a systematic review Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-03-01 G. Chene, H. Baffet, E. Cerruto, E. Nohuz, A. Agostini
The long-acting reversible contraception progestin subdermal implant (ENG implant) may be effective to improve endometriosis-related symptoms. Since adenomyosis is a histopathological form of endom...
-
Retraction Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-02-16
Published in The European Journal of Contraception & Reproductive Health Care (Ahead of Print, 2024)
-
Retraction Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-02-16
Published in The European Journal of Contraception & Reproductive Health Care (Ahead of Print, 2024)
-
Statement of Retraction [Sublingual misoprostol prior to insertion of a T380A intrauterine device in women with no previous vaginal delivery] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-02-08
Published in The European Journal of Contraception & Reproductive Health Care (Ahead of Print, 2024)
-
Impact of a post-partum family planning intervention on contraception and fertility in Tanzania: two-year follow-up of a cluster-randomised controlled trial Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-02-01 Julia K. Rohr, Sarah Huber-Krum, Angelica Rugarabamu, Erin Pearson, Joel M. Francis, Muqi Guo, Hellen Siril, Iqbal Shah, David Canning, Nzovu Ulenga, Till W. Bärnighausen
We evaluate contraceptive use and pregnancy two years following an intervention in Tanzania, which provided antenatal post-partum family planning counselling and post-partum intrauterine device (PP...
-
Hormonal contraception for female athletes presents special needs and concerns Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-02-01 Liron Seidman, Daniel S. Seidman, Naama W. Constantini
Oral contraceptives (OCs) are commonly used by female athletes raising concerns regarding the possible adverse effects of OCs on physical performance, musculoskeletal injuries, and bone density. We...
-
Is the multinational, surveillance PRO-E2 study informative for all countries? The Italian data on VTE and contraceptive effectiveness Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-02-01 Franca Fruzzetti, Angelo Cagnacci, Mitra Boolell, Costantino Di Carlo, Vincenzina Bruni
To evaluate whether the thromboembolic risk and contraceptive effectiveness of NOMAC-E2 observed in the PRO-E2 study can be extended to each participating country, as lifestyle, cardiovascular risk...
-
Do elevated thyrotropin levels increase the risk of miscarriages: yes or no? Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-02-01 Tatjana Barišić, Marjana Jerković Raguž, Ivona Šušak, Emil Babić, Svjetlana Grgić, Iva Mandić
To examine correlation between elevated levels of thyrotropin with the frequency of miscarriages.A cross-sectional study was conducted on the 380 respondents and it investigated TSH (thyrotropin), ...
-
Minimally invasive transurethral holmium laser surgery for the management of an IUD with bladder migration Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-01-29 Dawei Ni, Kun Liu, Mingming Lu, Can Wei, Yanbin Zhang
Intrauterine device (IUD) is used worldwide as an effective contraceptive method, but the migration of IUD is a serious complication. We report the case of IUD migration leading to bladder calculus...
-
Knowledge of non-contraceptive benefits of and willingness to consider taking oral contraceptive pills among a low-risk female population: a cross-sectional study Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2024-01-29 Caitlin Alsandria O’Hara, Teoh Wei Shan, Joseph Ng Soon Yau
In addition to its widely-appreciated contraceptive applications, the oral contraceptive pill (OCP) conveys both oncological and non-oncological benefits. Oncological benefits include a decreased r...
-
Contraceptive switch and abandonment among women using the pill, condoms and injectables in Brazil Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-12-18 Christiane Borges do Nascimento Chofakian, Ana Luiza Vilela Borges
The aim of our study was to assess the covariates of contraceptive switching and abandonment among Brazilian women stratified by oral pills, condoms and injectables.Women attending primary health c...
-
Statement of Retraction [A novel association between cytotoxin-associated gene A (CagA) positive strain of Helicobacter pylori and unexplained recurrent early pregnancy loss] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-11-30
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 6, 2023)
-
Oral hormonal therapy as treatment option for abnormal uterine bleeding Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-11-30 Chiara Selmi, Antonio La Marca
abnormal uterine bleeding is a very frequent reason for referral to gynaecologists and can deeply influence the quality of life. Once organic causes requiring surgical treatment are ruled out, clin...
-
Knowledge, attitudes, and perceptions of health care providers regarding the recommendation and use of long-acting reversible contraceptive devices for adolescent patients Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-11-30 Fernando A. Ávila-Sánchez, Daniela Sarria-Ortiz, Camilo Hernán Bonilla-Cortés, Laura Camila Solarte-Solarte, Catalina Cerón-Garcés, Laura Libreros-Peña, Evelyn E. Peña-Zárate, Juan Sebastián Galindo-Sánchez, Annie Melissa Quintero, María Fernanda Escobar
To describe the knowledge, attitudes, and perceptions of healthcare providers in a region in southwestern Colombia regarding the recommendation and use of long-acting reversible contraceptive (LARC...
-
Menstrual cycle abnormalities in women: characteristics, perceptions, and health-seeking behaviours Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-11-30 Hülya Özberk, Dilek Bilgiç, Aysun Badem
To evaluate menstruation characteristics, perceptions, and health-seeking behaviours in women.We conducted this cross-sectional study with 394 women between February 2021 and October 2021. Accordin...
-
A new progestin-only pill (POP): the impact of drospirenone-only pill 4 mg 24 + 4 on coagulation markers and bleeding patterns Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-11-30 Maurizio Guida, Luciano Quercitelli, Pasquale De Franciscis, Cinzia Ferrara, Marco Marietta, Mattia Iaccheri, Fabio Facchinetti, Filomena Capasso, Giovanni Grandi
Progestin-only pills (POPs), compared to combined, are not associated with an increased risk of venous thromboembolism, but are associated with a poor cycle control. The aim of this study was to ev...
-
Site necrosis at the insertion place of the single-rod subdermal contraceptive implant: report of five cases Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-11-30 María D. Faranna, Analía C. Pesado
Implant-site necrosis is a rare complication. We present a case-series of a necrosis as an adverse effect after the etonogestrel (ENG)-subdermal contraceptive implant placement.Five women with site...
-
Statement of Retraction [Can Porphyromonas gingivalis be a novel aetiology for recurrent miscarriage?] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-11-30
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 6, 2023)
-
Statement of Retraction [Ultrasound-guided versus uterine sound-sparing approach during copper intrauterine device insertion: a randomised clinical trial] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-11-30
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 6, 2023)
-
Ultrasound beyond the patient’s wishes requires more consideration Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-10-30 Chenlin Pei, Yuelan Liu, Weishe Zhang, Liangqun Xie, Jingrui Huang
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 5, 2023)
-
The use and access to contraception in Sweden during the COVID-19 pandemic period Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-10-30 Niklas Envall, Kristina Gemzell Danielsson, Helena Kopp Kallner
Explore perceived access to, the need for, use of, and satisfaction with telemedicine services for contraceptive counselling and prescription-renewal-only during the COVID-19 pandemic, and the impa...
-
Preabortion ultrasound – a patient perspective Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-09-12 Volodymyr Podolskyi, Kristina Gemzell-Danielsson, Lena Marions, Rebecca Gomperts
To explore women’s perception of the need for an ultrasound scan before medical abortion provided by telemedicine services.We have analysed women’s requests for medical abortion through the website...
-
Statement of Retraction [Different analgesics prior to intrauterine device insertion: is there any evidence of efficacy?] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-08-29
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 5, 2023)
-
The contraceptive choice at the time of a surgical and pharmacological abortion: a possible and effective option thanks to a dedicate counselling Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-08-17 Paola Algeri, Laura Colonna, Vanda Savoldi, Laura Imbruglia, Nunzia Mastrocola, Silvia Von Wunster
The percentage of repeat abortion in Italy is about 25%. It is therefore important to implement the strategies that can facilitate the adoption of the most effective contraceptive methods. Long-act...
-
The criminalisation of women’s healthcare in the post-Dobbs era: an analysis of the anti-abortion trigger law statutes Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-08-17 Kristina Domanski, Michael Allswede
On 24 June 2022, the U.S. Supreme Court’s decision in Dobbs v. Jackson Women’s Health Organisation held that:‘The Constitution does not confer a right to abortion; Roe and Casey are overruled; and ...
-
Statement of Retraction [Effect of a mobile phone-assisted postpartum family planning service on the use of long-acting reversible contraception: a randomised controlled trial] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-08-17
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 5, 2023)
-
Statement of Retraction [Self-administrated vaginal 2% lidocaine in-situ gel for pain relief during copper intrauterine device insertion in women with previous caesarean delivery only: a randomised, double-blind placebo-controlled trial] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-08-17
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 5, 2023)
-
Provision of contraceptives by Brazilian general gynaecologists: a nationwide online survey Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-07-28 Mariana R. M. Canela, Luiz G. O. Brito, Agnaldo Lopes Silva-Filho, Luis Bahamondes, Cássia R. T. Juliato
To assess the provision of contraceptives by Brazilian obstetricians and gynaecologists (Obst/Gyns) during medical consultation and associated factors.An anonymous online survey was conducted with ...
-
Clinical improvement after Essure® devices removal: a systematic review Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-07-19 Chloe Miguet-Bensouda, Francois Parant, Guillaume Grenet, Emanuele Cerruto, Erdogan Nohuz, Gautier Chene
Abstract Purpose Essure® implant is a permanently implanted minimally invasive birth control device for women (female sterilisation) widely used between 2002 and 2018. Many adverse events were reported by patients. Increasingly removal procedures have been performed in symptomatic patients. However, there is a lack of in-depth studies on clinical improvement after Essure® removal. We aimed to review
-
The impact of combined contraceptive vaginal ring on vaginal environment: an observational, longitudinal study Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-07-07 Filippo Murina, Alessandra Graziottin, Stefania Di Francesco, Dario Recalcati
Abstract Purpose To assess the relationship between combined contraceptive vaginal ring (CVR) and vaginal microbiome using 16S rRNA gene sequencing. Materials and methods We enrolled 20 women for 8 weeks in an open-label study using CVR (NuvaRing®) that delivered 15 mcg ethinylestradiol and 120 mcg etonogestrel daily. The vaginal microbiome was assessed at baseline and after 2 months by sequencing
-
Clinical and histopathological correlations in symptomatic patients with salpingectomy for Essure® implant removal: a cross-sectional study Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-06-27 Alexis Trecourt, Mojgan Devouassoux-Shisheboran, Erdogan Nohuz, Emanuele Cerruto, Stephanie Moret, Doriane Hallez, Chloe Miguet-Bensouda, Gautier Chene
Abstract Purpose Many concerns have been raised about adverse effects related to Essure® device. Several pathophysiological hypotheses have been proposed including allergic reactions, Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants, galvanic corrosion with release of heavy metals and inflammation. In the present study, we aimed to focus on inflammation process by performing a histopathological
-
Expulsion and continuation rates of the 52 mg levonorgestrel intrauterine system in adolescents and adult women Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-06-19 Eliza Brull, Helymar C. Machado, Luis Bahamondes, Cássia R. T. Juliato
Abstract Objective To compare the continuation rates, expulsion, and other reasons for discontinuation of the hormonal intrauterine device with 52 mg of levonorgestrel (52 mg LNG-IUD) in adolescents and adult women. Methods We conducted a retrospective cohort study that included 393 women in whom we placed a 52 mg LNG-IUD and followed up to 5 years. We created two retrospective cohorts, one with 131
-
The love-shaper: role of the foetus in modulating mother-child attachment through stem cell migration to the maternal brain Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-06-09 Mario Valerio Tartagni, Alessandra Graziottin
Abstract Background Foetal PAPCs (pregnancy-associated progenitor cells) begin to cross the placenta in a scheduled manner from early pregnancy and colonise many maternal organs, both in mammals and humans, during each pregnancy. The maternal limbic system appears to be colonised with a 100% frequency when compared with other maternal organs. Once they arrive in the limbic system, foetal PAPCs differentiate
-
High-intensity focussed ultrasound and hysteroscopy endo-operative system cold device procedures for treating >4cm diameter FIGO Type 2 uterine myoma and ensuring successful pregnancy Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-06-02 Sha Liao, Xiaoli Wang, Na Fu, Yan Huang
Abstract Purpose Laparotomic or hysteroscopic myomectomy, and high-intensity focussed ultrasound (HIFU), can be used in the treatment of Type 2 myomas with a > 50% intramural component. Hysteroscopic electroresection may damage the remaining endometrium and complete ablation of myomas may not be realised via HIFU treatment. We report and examine the results of 1 case of HIFU treatment, accompanied
-
Women's perspectives on impact on the post menopause of use of the 52 mg levonorgestrel intrauterine device during the menopausal transition Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-05-30 Jacques B. E. Versailles, Sherly Metelus, Alessandra Peloggia, Montas Laporte, Luis Bahamondes, Cassia Juliato
Abstract Objectives To assess perimenopausal users of 52 mg levonorgestrel intrauterine devices (LNG-IUD) regarding the IUD impact after menopause. Material and methods a cross-sectional study with users aged 40 and 49 years old, without cognitive impairment that answered a questionnaire regarding worries and benefits after the menopause due to LNG-IUD use. Results Almost half of 221 users (52.9%)
-
Can transvaginal cervical length and cervical strain elastography predict mid-trimester medical induction to abortion intervals? Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-05-10 Seçil Karaca Kurtulmuş, Ibrahim Omeroglu, Mustafa Sengul
Abstract Objective Mid-trimester pregnancy terminations are becoming an increasingly common practice in obstetrics. Accurate prediction of delay from induction to abortion may help in planning the optimal time for the medical induction process and optimising the use of healthcare services. Therefore, we aimed to assess whether the transvaginal cervical length and cervical elastography can predict the
-
Statement of Retraction [Lidocaine gel vs lidocaine spray in reducing pain during insertion of the intrauterine contraceptive device] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-05-05
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 4, 2023)
-
Endometriosis features and dienogest tolerability in women with depression: a case-control study Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-05-03 Hanna Dietrich, Chiara Knobel, Lea Portmann, Julian Metzler, Anne Muendane, Angela Niggli, Maria S. Neumeier, Patrick Imesch, Gabriele S. Merki-Feld
Abstract Objective Primary aim of this study was to investigate endometriosis characteristics of patients with psychiatric conditions or depression. The secondary aim was to study tolerability of dienogest in this context. Methods This observational case-control study included endometriosis data from patients visiting our clinic from 2015–2021. We collected information from patient charts and in phone
-
Statement of Retraction [Ultrasound-guided intrauterine device insertion: a step closer to painless insertion: a randomized control trial] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-04-18
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 3, 2023)
-
Statement of Retraction [Post-placental intrauterine device insertion vs puerperal insertion in women undergoing caesarean delivery in Egypt: a 1 year randomised controlled trial] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-04-18
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 4, 2023)
-
Statement of Retraction [Current contraceptive trends among married Egyptian women: a cross-sectional survey] Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-04-18
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 3, 2023)
-
The role of combined oral contraceptives containing norgestimate for acne vulgaris treatment: a review Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-04-12 Giovanni Grandi, Gloria Guariglia, Fabio Facchinetti
Abstract Introduction Both Food and Drugs Administration and European Medicine Agency (EMA) approve the use of a triphasic combined oral contraceptive (COC) containing ethinyl-oestradiol (EE) and norgestimate (NGM) for acne vulgaris treatment in women requiring an effective contraception. COCs can target sebum production and may also play a role in decreasing follicular hyperkeratinisation. Results
-
The levonorgestrel-releasing intrauterine system 52 mg as a contraceptive versus a therapeutic: essential differences and perspectives Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-04-12 Norman D. Goldstuck
Abstract Background It is 100 years since the discovery of oestrogen and nearly that since the discovery of progesterone. It is over 50 years since the concept of using intrauterine progesterone. Ten years after its synthesis, the research using levonorgestrel as an intrauterine agent was introduced. Areas covered The pharmacodynamics and pharmacokinetics of LNG-IUSs and the LNG-IUS 52 mg in particular
-
Exploring technology-based interventions to improve oral contraceptive pill adherence: a cross-sectional survey Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-04-04 Anne Flynn, Rachel Galvao, Isabella Joslin, Arden McAllister, Nathanael C. Koelper, Sarita Sonalkar
Abstract Purpose To assess the resources that oral contraceptive pill (OCP) users currently use and wish to use after missing pills. Materials and Methods People 18–44 years old with a OCP prescription were emailed a cross-sectional survey to assess how they obtain information about managing missed pills, what information they would prefer to access, and whether they would use additional information
-
Keeping you posted: analysis of fertility-related social media posts after introduction of the COVID-19 vaccine Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-03-30 Jillian Pecoriello, Nicole Yoder, Meghan B. Smith, Jennifer K. Blakemore
Abstract Purpose Our objective was to analyse information and sentiments posted regarding the COVID-19 vaccine on fertility-related social media. Materials and Methods The first fifty accounts on Instagram and Twitter were identified with the terms: fertility doctor, fertility, OBGYN, infertility, TTC, IVF. Accounts were categorised as physician (PH), individual (ID), or fertility center/organisation
-
Does change in the shape of intrauterine contraceptive device Cu 375 and Cu T 380A affect the expulsion after post-partum insertion – a prospective randomized control trial Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-03-30 C. Nitesh, Charu Sharma, Shashank Shekhar, Pratibha Singh, Manisha Jhirwal, Meenakshi Gothwal, Manoj Kumar Gupta
Abstract Purpose The objective of the study was to see the difference in expulsion rates of two types of Copper containing intrauterine contraceptive devices (IUCDs): Cu 375 & CuT 380 A, within or at 6 weeks after insertion. Methods It was a randomised control trial. A total of 396 pregnant women were recruited. Ultrasonography was done to look for the position of the IUCD at the time of discharge
-
Usage of postpartum intrauterine contraceptive device (postpartum-IUD) after an increase in the institutional delivery rate in India: time to re-visit the effect of timing of counselling on its acceptance Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-03-27 Nancy Bhagat, Rimpi Singla, Minakshi Rohilla, Aashima Arora, Vanita Suri
Abstract Purpose While increase in institutional deliveries brings an opportunity to counsel women for postpartum family planning (PPFP), its uptake remains low. Reasons for poor acceptance of postpartum intrauterine contraceptive device (postpartum-IUD), and its relation with the timing of counselling need to be investigated. Methods Women attending the antenatal clinic, reporting in labour, and within
-
Perception of oral contraception – do women think differently from gynaecologists? Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-03-27 Fátima Palma, Ana Rosa Costa, Joaquim Neves, Amália Pacheco, M. Céu Almeida, Teresa Bombas, Daniel P. Silva
Abstract Purpose This study aimed to assess the experience and satisfaction with contraceptives and use of Combined Oral Contraceptives (COC) by women and compare their perceptions with those of gynaecologists. Methods This was a multicentre survey study conducted in Portugal, during April and May, 2021 with women using contraceptives and gynaecologists. Online quantitative questionnaires were carried
-
Assessment of pain and ease of intrauterine device placement according to type of device, parity, and mode of delivery Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-03-24 Elaine A. Lopes-Garcia, Elenice V. Carmona, Ilza Monteiro, Luis Bahamondes
Abstract Objective We compared pain and the ease of insertion of two different types of intrauterine devices (IUDs; the levonorgestrel intrauterine systems 52 mg (LNG-IUS 52 mg) and the copper-bearing IUD [TCu380A]) among nulligravidas and parous women with and without caesarean delivery. Methods A cross-sectional study assessed pain referred by women and ease of insertion of the two IUDs models. We
-
Correction Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-03-13
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 2, 2023)
-
Authors response to article retraction Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-02-27 Ahmed Mohamed Maged
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 2, 2023)
-
Editors’ response Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-02-27 Giovanni Grandi, Frans Roumen, Johannes Bitzer
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 2, 2023)
-
Interventions to support contraceptive choice and use: a global systematic map of systematic reviews Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-02-20 Preethy D’Souza, Tenzin Phagdol, Sonia R. B. D’Souza, D. S. Anupama, Baby S. Nayak, Binil Velayudhan, Julia V. Bailey, Judith Stephenson, Sandy Oliver
Abstract Background To review the highest level of available evidence, a systematic map identified systematic reviews that evaluated the effectiveness of interventions to improve contraception choice and increase contraception use. Methods Systematic reviews published since 2000 were identified from searches of nine databases. Data were extracted using a coding tool developed for this systematic map
-
User satisfaction with an intrauterine system containing 52 mg levonorgestrel: a Portuguese study Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-02-20 Cristina Nogueira-Silva, Ana Rolhas, Irina Ramilo, Marta Plancha, Daniel Pereira da Silva
Abstract Objective To characterise patient satisfaction 6 and 12 months after insertion of a 52 mg levonorgestrel‐releasing intrauterine system (LNG-IUS) in Portuguese women. Study design A non-interventional and prospective study was conducted in Portuguese women of reproductive age who had Levosert® inserted. Two questionnaires (administered 6 and 12 months after 52 mg LNG-IUS insertion) were used
-
Multiple induced abortions – implications for counselling and contraceptive services from a multi-centre cross-sectional study in Sweden Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-02-20 Cerisa Obern, Maria Ekstrand Ragnar, Tanja Tydén, Margareta Larsson, Jenny Niemeyer Hultstrand, Kristina Gemzell-Danielsson, Inger Sundström-Poromaa, Marlene Makenzius
Abstract Objectives To investigate factors associated with multiple induced abortions. Materials and methods A multi-centre cross-sectional survey among abortion-seeking women (n = 623;14-47y) in Sweden, 2021. ‘Multiple abortions’ was defined as having had ≥2 induced abortions. This group was compared to women with a previous experience of 0-1 induced abortion. Regression analysis was conducted to
-
What is the optimal tool for measuring abortion stigma? A systematic review Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-02-20 Sarah E. Ratcliffe, Clare S. Smylie, Rebecca T. Pinkus, Ilan Dar-Nimrod, Ilona Juraskova, Haryana M. Dhillon
Abstract Purpose Abortion stigma is a barrier to accessing and delivering comprehensive, sustainable healthcare. This study aimed to systematically identify measures of abortion stigma, and assess their psychometric properties and uses. Materials and methods The systematic review was preregistered with PROSPERO (ID#127339) and adhered to Preferred Reporting Items for Systematic Reviews and Meta-Analyses
-
Acceptance rate of post-placental plac ement of intrauterine devices during the SARS-CoV-2 (COVID-19) pandemic Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-02-20 Rodolfo R. Jacapenga, Fernanda Surita, Luis Bahamondes, Cássia R. T. Juliato
Abstract Objective To evaluate the acceptance rate of post-placental intrauterine device (PPIUD) placement during the SARS-CoV-2 (COVID-19) pandemic and to to assess factors associated with PPIUD acceptance. Methods A cross-sectional study was conducted between August 2020 and August 2021. PPIUDs were offered to women scheduled for caesarean delivery or admitted in labour at the Women’s Hospital of
-
How often is oral contraception used for contraception? The need of benefit’s formalisation Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-02-10 Angelo Cagnacci, Vincenzina Bruni, Costantino Di Carlo, Franca Fruzzetti
Published in The European Journal of Contraception & Reproductive Health Care (Vol. 28, No. 2, 2023)
-
Telemedicine medical abortion service in Georgia: an evaluation of a strategy with reduced number of in-Clinic visits Eur. J. Contracept. Reprod. Health Care (IF 1.7) Pub Date : 2023-02-08 Nino Tsereteli, Lia Mamatsashvili, George Tsertsvadze, Tamar Tsereteli, Ingrida Platais
Abstract Purpose To evaluate feasibility and acceptability of a medical abortion service that offers: a telemedicine visit (in place of an in-person visit) during a mandatory waiting period, and at-home follow-up with the use of multi-level pregnancy tests (MLPT). Methods Participants were screened for eligibility in clinic, and during the waiting period, received a telephone call to confirm desire